CLINICAL_TRIALS trial_result · 2015-06-22

Clinical Trial Update: Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change [Phase 4]

Phase 4 clinical trial in relapsing-remitting multiple sclerosis evaluating candidates for changing MS therapy; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2015-06-22